VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27 | -85.8% | 2,495 | -86.7% | 0.00% | -88.9% |
| Q2 2023 | $190 | -24.0% | 18,706 | -57.1% | 0.03% | +8.0% |
| Q1 2023 | $250 | +71.2% | 43,595 | -29.0% | 0.02% | +108.3% |
| Q4 2022 | $146 | -99.3% | 61,400 | +340.6% | 0.01% | +500.0% |
| Q3 2022 | $22,000 | -8.3% | 13,934 | -3.5% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -38.5% | 14,434 | -21.3% | 0.00% | 0.0% |
| Q1 2022 | $39,000 | -72.9% | 18,334 | -53.3% | 0.00% | -75.0% |
| Q1 2020 | $144,000 | +260.0% | 39,300 | +327.2% | 0.01% | +300.0% |
| Q4 2019 | $40,000 | -27.3% | 9,200 | -8.0% | 0.00% | -60.0% |
| Q3 2019 | $55,000 | -16.7% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $66,000 | -18.5% | 10,000 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $81,000 | -19.0% | 10,000 | -39.4% | 0.01% | -20.0% |
| Q4 2018 | $100,000 | -78.0% | 16,500 | -66.9% | 0.01% | -68.8% |
| Q3 2018 | $454,000 | +135.2% | 49,830 | -26.6% | 0.03% | +113.3% |
| Q2 2018 | $193,000 | – | 67,870 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |